rs11574556

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_003123.6(SPN):​c.675C>G​(p.Ser225Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00367 in 1,614,184 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars). Synonymous variant affecting the same amino acid position (i.e. S225S) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0028 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0038 ( 8 hom. )

Consequence

SPN
NM_003123.6 missense

Scores

1
17

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: -1.12

Publications

3 publications found
Variant links:
Genes affected
SPN (HGNC:11249): (sialophorin) This gene encodes a highly sialylated glycoprotein that functions in antigen-specific activation of T cells, and is found on the surface of thymocytes, T lymphocytes, monocytes, granulocytes, and some B lymphocytes. It contains a mucin-like extracellular domain, a transmembrane region and a carboxy-terminal intracellular region. The extracellular domain has a high proportion of serine and threonine residues, allowing extensive O-glycosylation, and has one potential N-glycosylation site, while the carboxy-terminal region has potential phosphorylation sites that may mediate transduction of activation signals. Different glycoforms of this protein have been described. In stimulated immune cells, proteolytic cleavage of the extracellular domain occurs in some cell types, releasing a soluble extracellular fragment. Defects in expression of this gene are associated with Wiskott-Aldrich syndrome. [provided by RefSeq, Sep 2017]
QPRT (HGNC:9755): (quinolinate phosphoribosyltransferase) This gene encodes a key enzyme in catabolism of quinolinate, an intermediate in the tryptophan-nicotinamide adenine dinucleotide pathway. Quinolinate acts as a most potent endogenous exitotoxin to neurons. Elevation of quinolinate levels in the brain has been linked to the pathogenesis of neurodegenerative disorders such as epilepsy, Alzheimer's disease, and Huntington's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004766196).
BP6
Variant 16-29664403-C-G is Benign according to our data. Variant chr16-29664403-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 3037910.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAdExome4 at 8 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003123.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPN
NM_003123.6
MANE Select
c.675C>Gp.Ser225Arg
missense
Exon 2 of 2NP_003114.1P16150
SPN
NM_001030288.4
c.675C>Gp.Ser225Arg
missense
Exon 2 of 2NP_001025459.1P16150

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPN
ENST00000652691.1
MANE Select
c.675C>Gp.Ser225Arg
missense
Exon 2 of 2ENSP00000498852.1P16150
SPN
ENST00000360121.4
TSL:1
c.675C>Gp.Ser225Arg
missense
Exon 2 of 2ENSP00000353238.3P16150
SPN
ENST00000395389.2
TSL:1
c.675C>Gp.Ser225Arg
missense
Exon 2 of 2ENSP00000378787.2P16150

Frequencies

GnomAD3 genomes
AF:
0.00281
AC:
428
AN:
152200
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00111
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00694
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00378
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00238
AC:
598
AN:
251422
AF XY:
0.00233
show subpopulations
Gnomad AFR exome
AF:
0.000984
Gnomad AMR exome
AF:
0.00387
Gnomad ASJ exome
AF:
0.000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00365
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00376
AC:
5492
AN:
1461866
Hom.:
8
Cov.:
31
AF XY:
0.00368
AC XY:
2675
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33480
American (AMR)
AF:
0.00425
AC:
190
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00172
AC:
45
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.000206
AC:
11
AN:
53394
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00446
AC:
4963
AN:
1112010
Other (OTH)
AF:
0.00426
AC:
257
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
381
762
1143
1524
1905
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00281
AC:
428
AN:
152318
Hom.:
0
Cov.:
31
AF XY:
0.00271
AC XY:
202
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00111
AC:
46
AN:
41580
American (AMR)
AF:
0.00693
AC:
106
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00378
AC:
257
AN:
68034
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
23
45
68
90
113
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000464
Hom.:
3
Bravo
AF:
0.00303
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00285
AC:
11
ExAC
AF:
0.00198
AC:
240
EpiCase
AF:
0.00311
EpiControl
AF:
0.00397

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
SPN-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.37
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
0.10
DANN
Benign
0.67
DEOGEN2
Benign
0.32
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0065
N
LIST_S2
Benign
0.33
T
M_CAP
Benign
0.041
D
MetaRNN
Benign
0.0048
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.5
L
PhyloP100
-1.1
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.12
Sift
Benign
0.32
T
Sift4G
Benign
0.26
T
Polyphen
0.013
B
Vest4
0.11
MutPred
0.22
Gain of MoRF binding (P = 0.0148)
MVP
0.50
MPC
0.71
ClinPred
0.0065
T
GERP RS
-3.9
Varity_R
0.087
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11574556; hg19: chr16-29675724; COSMIC: COSV64070501; COSMIC: COSV64070501; API